Discovery of novel selective norepinephrine inhibitors: 1-(2-morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides (WYE-114152). [electronic resource]
Producer: 20111212Description: 6824-31 p. digitalISSN:- 1520-4804
- Acute Pain -- drug therapy
- Administration, Oral
- Analgesics -- chemical synthesis
- Animals
- Benzothiazoles -- chemical synthesis
- Biological Availability
- Cell Line
- Chronic Pain -- drug therapy
- Cricetinae
- Cyclic S-Oxides -- chemical synthesis
- Dogs
- Humans
- Inflammation -- drug therapy
- Injections, Intravenous
- Male
- Morpholines -- chemical synthesis
- Neuralgia -- drug therapy
- Norepinephrine Plasma Membrane Transport Proteins -- antagonists & inhibitors
- Rats
- Stereoisomerism
- Thiadiazoles -- chemical synthesis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.